Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 4/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Heilongjiang ZBD Pharmaceutical Co., Ltd. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CN¥11.24 |
52 Week High | CN¥14.37 |
52 Week Low | CN¥8.89 |
Beta | 0.29 |
11 Month Change | 1.81% |
3 Month Change | -9.57% |
1 Year Change | -19.02% |
33 Year Change | -31.25% |
5 Year Change | -2.18% |
Change since IPO | -33.84% |
Recent News & Updates
Does Heilongjiang ZBD Pharmaceutical (SHSE:603567) Have A Healthy Balance Sheet?
May 28Why Heilongjiang ZBD Pharmaceutical's (SHSE:603567) Earnings Are Better Than They Seem
May 06Insufficient Growth At Heilongjiang ZBD Pharmaceutical Co., Ltd. (SHSE:603567) Hampers Share Price
Apr 17Shareholder Returns
603567 | CN Pharmaceuticals | CN Market | |
---|---|---|---|
7D | 7.9% | 4.2% | -0.6% |
1Y | -19.0% | -10.6% | -22.0% |
Return vs Industry: 603567 underperformed the CN Pharmaceuticals industry which returned -10.6% over the past year.
Return vs Market: 603567 exceeded the CN Market which returned -22% over the past year.
Price Volatility
603567 volatility | |
---|---|
603567 Average Weekly Movement | 4.4% |
Pharmaceuticals Industry Average Movement | 5.1% |
Market Average Movement | 5.7% |
10% most volatile stocks in CN Market | 9.0% |
10% least volatile stocks in CN Market | 3.9% |
Stable Share Price: 603567 has not had significant price volatility in the past 3 months.
Volatility Over Time: 603567's weekly volatility (4%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1996 | 2,545 | n/a | www.zbdzy.com |
Heilongjiang ZBD Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of Chinese medicines in China. It offers cardiovascular and cerebrovascular, respiratory system, orthopedics, tumors, digestive system, anti-infection, mental nerve, genitourinary, and other disease fields. The company was founded in 1996 and is based in Hulin, China.
Heilongjiang ZBD Pharmaceutical Co., Ltd. Fundamentals Summary
603567 fundamental statistics | |
---|---|
Market cap | CN¥10.28b |
Earnings (TTM) | CN¥511.96m |
Revenue (TTM) | CN¥2.72b |
20.6x
P/E Ratio3.9x
P/S RatioIs 603567 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
603567 income statement (TTM) | |
---|---|
Revenue | CN¥2.72b |
Cost of Revenue | CN¥1.45b |
Gross Profit | CN¥1.27b |
Other Expenses | CN¥757.56m |
Earnings | CN¥511.96m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 27, 2024
Earnings per share (EPS) | 0.55 |
Gross Margin | 46.62% |
Net Profit Margin | 18.80% |
Debt/Equity Ratio | 39.5% |
How did 603567 perform over the long term?
See historical performance and comparison